Inactive Instrument

Analyst Reco. BIOLASE Inc Nasdaq

Equities

Ascendiant Capital Adjusts Biolase's Price Target to $4 From $15, Reiterates Buy Rating	Apr. 01	MT
Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday	Mar. 22	MT
Biolase Files Registration Statement for Unit Offering at Target Price of $60 a Unit	23-09-12	MT
Lake Street Adjusts Price Target on Biolase to $0.40 From $1.50, Maintains Buy Rating	23-05-31	MT
Lake Street Assumes Biolase at Buy With $1.50 Price Target	23-01-20	MT
Lake Street Initiates Biolase at Buy, Sets Price Target at $12	22-05-20	MT

No results for this search